Category: Manufacturing, Packaging & Detailing
Manufacturing, Packaging & Detailing market research reports by GlobalData
-
Bio/Pharmaceutical Outsourcing Report, May 2025
Bio/Pharmaceutical Outsourcing Report, May 2025 Summary The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing cont ... Read More
-
Bio/Pharmaceutical Outsourcing Report, April 2025
Bio/Pharmaceutical Outsourcing Report, April 2025 Summary The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing co ... Read More
-
Q1 2025 CRO Activity and Intel Report
Q1 2025 CRO Activity and Intel Report Summary This report offers an in-depth analysis of the contract research organization (CRO) industry, categorized by geography, therapeutic area, and phase of development for Q1 2025. Scope The Q1 CRO Activity and Intel report offers insights into CRO and sponso ... Read More
-
New US Administration: Looming Tariffs on Pharma Timelines
New US Administration: Looming Tariffs on Pharma Timelines Summary Within the first 100 days of the current US Administration, there has been a clear shift toward more protectionist trade policy. The 47th US President has implemented a series of tariff measures aimed at reducing the trade deficit. T ... Read More
-
Geopolitical, Macroeconomic, & Regulatory Changes Impacting the Pharmaceutical Industry
Geopolitical, Macroeconomic, & Regulatory Changes Impacting the Pharmaceutical Industry Summary Within the first 100 days of the current US Administration, there have been a series of changes in the US that will impact the pharmaceutical industry. To date, key outcomes have included - Leadership cha ... Read More
-
Looking Ahead to 2025 - the Future of Pharma
Looking Ahead to 2025 - the Future of Pharma Summary This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, an ... Read More
-
Bio/Pharmaceutical Outsourcing Report, March 2025
Bio/Pharmaceutical Outsourcing Report, March 2025 Summary The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing co ... Read More
-
Emerging Market Outsourcing Report - Q1 2025
Emerging Market Outsourcing Report - Q1 2025 Summary This expert outsourcing report is a comprehensive look at the pharmaceutical manufacturing landscape for emerging markets in Q1 2025, including analysis of news and trends affecting contract manufacturing organizations (CMOs) and the identificatio ... Read More
-
Bio/Pharmaceutical Outsourcing Report, February 2025
Bio/Pharmaceutical Outsourcing Report, February 2025 Summary The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing ... Read More
-
Sawai Pharmaceutical Co Ltd - Strategic SWOT Analysis Review
Sawai Pharmaceutical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product ... Read More
-
Venture Capital Investment Trends In Pharma - Q1 2025
Venture Capital Investment Trends In Pharma - Q1 2025 Summary This report analyzes the venture capital (VC) investment activity in Q1 2025 in the Pharma sector. The global pharma sector in Q1 2025 witnessed investments worth $6.5 billion, an increment of 0.5% compared to Q4 2024. In terms of investm ... Read More
-
M&A Trends in Pharma - Q1 2025
M&A Trends in Pharma - Q1 2025 Summary This report analyzes the merger and acquisition (M&A) activity in Q1 2025 in the Pharma sector. The global pharma sector in Q1 2025 witnessed deals worth $37.7 billion, an increment of 100.4% compared to Q4 2024. In terms of deal volume, there was a decline of ... Read More
-
Pharmaceutical Review Designations: Trends and Industry Insights
Pharmaceutical Review Designations: Trends and Industry Insights Summary This report investigates review designations in the pharmaceutical industry from the standpoint of drug development. It provides an in- depth review of the history and available designations alongside high-level analysis of key ... Read More
-
Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2024 Edition
Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2024 Edition Summary This expert trend report is a comprehensive look at the pharmaceutical finished dose contract manufacturing landscape in 2024, including analysis of dose CMO M&A activity, market s ... Read More
-
Strategic Intelligence: Pharma M&A Deals Q3 2024 - Top Themes
Strategic Intelligence: Pharma M&A Deals Q3 2024 - Top Themes Summary This report analyzes the disruptive themes that have driven M&A activity in Q3 2024 in the pharma Sector. The global pharma sector in Q3 2024 witnessed deals worth $35 billion, a decline of 3% compared to Q3 2023. In terms of deal ... Read More
-
Pharmaceuticals - Enterprise ICT
Pharmaceuticals - Enterprise ICT Summary The Pharmaceuticals Enterprise ICT Country Intelligence Report, a new Vertical Intelligence Report by GlobalData, summarizes key findings from GlobalData’s ICT Customer Insight Survey carried out in H1-2024 and GlobalData’s Market Opportunity Forecasts to 202 ... Read More
-
Strategic Intelligence: Orphan Designated Drugs
Strategic Intelligence: Orphan Designated Drugs Summary This report consolidates GlobalData’s latest thinking and forecasts around how the healthcare, macroeconomic, technology, and regulatory trends will impact the orphan designated drugs in pharma space, as well as providing insights into the lead ... Read More
-
Pharmaceutical Drug Development Annual Review - 2023
Pharmaceutical Drug Development Annual Review - 2023 Summary This report investigates the year 2023 in the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based ana ... Read More
-
Rohto Pharmaceutical Co Ltd (4527) - Financial and Strategic SWOT Analysis Review
Rohto Pharmaceutical Co Ltd (4527) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
M&A in the Contract Manufacturing Industry: Implications and Outlook – 2024 Edition
M&A in the Contract Manufacturing Industry: Implications and Outlook – 2024 Edition Summary This report is the fifth edition of our analysis of mergers and acquisitions in the pharmaceutical contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight ... Read More
-
Thematic Intelligence: Pharma M&A Deals Q2 2024 - Top Themes
Thematic Intelligence: Pharma M&A Deals Q2 2024 - Top Themes Summary This report analyzes the disruptive themes that have driven M&A activity in Q2 2024 in the pharma Sector. The global pharma sector in Q2 2024 witnessed deals worth $34 billion, a decline of 38% compared to Q2 2023. In terms of deal ... Read More
-
Thematic Intelligence: Cybersecurity in Healthcare (2024)
Thematic Intelligence: Cybersecurity in Healthcare (2024) Summary Cyberattacks are a major threat to the healthcare sectorWeak cybersecurity measures expose companies to serious risks. Victim companies suffer operationally, as systems are rendered unusable; reputationally, as customers lose trust; a ... Read More
-
Pharmaceutical Packaging Market Trends and Analysis Report By Material (Glass, Plastic, Paper & Paperboard, Metals, Rubber), Packaging Type, Distribution Channel, Region, and Segment Forecast to 2030
Pharmaceutical Packaging Market Trends and Analysis Report By Material (Glass, Plastic, Paper & Paperboard, Metals, Rubber), Packaging Type, Distribution Channel, Region, and Segment Forecast to 2030 Summary The pharmaceutical packaging market is primarily characterized by the increasing global dema ... Read More
-
Looking Ahead to 2024 - the Future of Pharma
Looking Ahead to 2024 - the Future of Pharma Summary This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, an ... Read More
-
Thematic Intelligence: Net Zero Strategies in the Pharmaceutical Sector
Thematic Intelligence: Net Zero Strategies in the Pharmaceutical Sector Thematic Intelligence: Net Zero Strategies in the Pharmaceutical Sector Summary Companies achieve net zero emissions by cutting greenhouse gas emissions to as close to zero as possible, with any remaining emissions then “offset. ... Read More
Research Assistance
